Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling

Kun Zuo1, Chen Fang1, Zheng Liu1

  • 1Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Insights

Short-chain fatty acids (SCFAs) from gut bacteria may protect against atrial fibrillation (AF). Supplementing SCFAs reduced AF markers and NLRP3 inflammasome activation, suggesting a therapeutic role.

Area of Science:

  • Cardiology
  • Microbiology
  • Metabolomics

Background:

  • Gut dysbiosis and NLRP3 inflammasome activation are linked to atrial fibrillation (AF).
  • The role of short-chain fatty acids (SCFAs), microbial metabolites of dietary fiber, as mediators in AF development is unclear.

Purpose of the Study:

  • To investigate whether SCFAs alleviate NLRP3 signaling-mediated atrial remodeling and protect against AF development.

Main Methods:

  • Cross-sectional study of 48 individuals using GC-MS metabolomics to correlate fecal SCFA levels with AF traits.
  • Murine models fed low- or high-fiber diets to assess SCFA's role in AF susceptibility, atrial remodeling, and GPR43/NLRP3 signaling.
  • In vitro validation using HL-1 cells.

Main Results:

  • AF patients exhibited reduced fecal SCFA levels, correlating with AF severity.
  • Low-fiber diet in mice increased AF susceptibility and atrial remodeling, effects reversed by SCFA supplementation.
  • SCFAs prevented NLRP3 inflammasome activation, fibrosis, and key signaling pathway dysregulation in atrial tissue.

Conclusions:

  • SCFAs derived from dietary fiber fermentation alleviate AF development.
  • SCFA exerts protective effects via the GPR43/NLRP3 signaling pathway.